Patient experience and unmet needs in high-risk nonmuscle-invasive bladder cancer: Insights from qualitative interviews and a cross-sectional survey

CONCLUSIONS: Most HR-NMIBC patients were satisfied overall with BCG treatment. Approximately half of the patients had stopped BCG treatment, notably, most during the induction phase, suggesting nonadherence to guidelines which recommend maintenance treatment after induction. Future treatments should focus on delaying or avoiding recurrence and cystectomy while reducing patient discomfort and discontinuation prior to completing the recommended course of treatment.PMID:38272755 | DOI:10.1016/j.urolonc.2024.01.013

Source: Urologic Oncology - January 25, 2024 Category: Urology & Nephrology Authors: Lewis Kopenhafer Allison Thompson Jane Chang Slaven Sikirica Elizabeth T Masters Joseph C Cappelleri Eugenia Y Peck Martine C Maculaitis Source Type: research